The global industry was valued US$ 5.8 Billion in 2022. With 17.4% projected growth from 2023 to 2033, the market is expected to reach a valuation of US$ 33.9 Billion by the end of the forecast period.
Cell Therapy is expected to be the highest revenue-generating form of cell and gene therapy manufacturing services, projected to grow at a CAGR of over 17.1% from 2023 to 2033.
As per the research of the Cell and Gene Therapy Manufacturing Services Market by Transparency Market Research - a market research and competitive intelligence provider, historically, from 2017 to 2022, the value of the cell and gene therapy manufacturing services industry increased at around 13.9% CAGR. With an absolute dollar opportunity of US$ 27.1 Billion, the market is projected to reach a valuation of US$ 33.9 Billion by 2033.
The key drivers influencing the market expansion include its health benefits, including the treatment of blood cancers, lymphomas, leukemia, and solid tumors, and the treatment of multiple myeloma.
Cell and gene therapy manufacturing services are a process of introducing cells or genes into the patients to treat a disease. The cells or genes can be sourced from the patient himself, or a donor. They are cultured during the production process, after which they are purified and packaged for delivery to the patient. The patient receives the cells or genes through injection or infusion.
In 2018, cancer was the second leading cause of death globally, accounting for over 9.6 million deaths, an average of one in six deaths. Cell and gene therapy treatment is widely used for treating various types of cancers which is escalating its demand consequently driving the cell and gene therapy manufacturing services.
The Food and Drug Administration approved the first CAR T cell therapy in 2017, and over 90% of people with a specific form of leukemia fully recovered from this treatment.
In 2018, there were 437 thousand of new cases of leukemia and 309 thousand cancer deaths from leukemia worldwide. Healthcare professionals widely used CAR T cell therapy for the treatment of specific blood cancers in certain age groups.
Single-use technologies are being used more in the biotechnology industry because of their adaptability and simplicity in the production of cell and gene therapy. Due to the increased use of cell and gene technology, cell culture can help to improve manufacturing efficiency and consistency, and also help to reduce manufacturing costs.
North America is a prominent market for Cell and Gene Therapy Manufacturing Services with a market size of US$ 2.3 Billion in 2022. The regional market is estimated to reach US$ 2.7 Billion in 2023. It is projected that the region will have a market worth US$ 13.9 Billion by 2033.
In 2020, cancer was the leading cause of death in the U.S. Over 18 Million new cases of cancer were diagnosed and 6 Million patients died due to cancer. These statistics have been propelling the Cell and Gene Therapy Manufacturing Services demand.
Sickle Cell disease (SCD) is the most common disease in the United States, affecting 1 in 500 Americans. Over 3 million infants are born with sickle cell anemia annually. Due to advancements in cell and gene therapy technologies, such as CRISPR-Cas9 gene editing technology is useful for the treatment of sickle cell anemia. This influences the growing need for cell and gene therapy manufacturing services.
The market in the United States is expected to grow to be worth US$ 12 Billion by 2033, with an absolute dollar growth of US$ 9.6 Billion from 2023 to 2033. The market in the United States has grown at a CAGR of 11.2% from 2017 to 2022 and is expected to grow at a CAGR of 17.2% from the year 2023 to 2033.
In the United States, Ischemic heart disease and stroke were the leading cause of death, and due to ischemic heart disease around 8.9 million people died. Furthermore, because of stroke, nearly 6.2 Million people died in 2019. Due to the increase in the number of patients, suffering from cardiovascular diseases, cell, and gene therapy is widely used for treatment, which influences the demand for cell and gene therapy manufacturing services.
The market in the United Kingdom is expected to grow to be worth US$ 1.4 Billion by 2033, with an absolute dollar growth of US$ 1.1 Billion. The market in the country has grown at a CAGR of 10.4% from 2017 to 2022 and is expected to grow at a CAGR of 16.4% from 2023 to 2033.
In 2018, According to Cancer Research UK, over 3.7 million cancer cases was diagnosed and around 1.6 million peoples died due to various types of cancer. Due to the increasing number of cancer patients, the UK government has been investing heavily in the development of cell and gene therapies and supporting the growth of cell and gene therapy manufacturing services. In 2020, the UK government invested US$ 4.7 Million in the development of cell and gene therapy.
The market in France is expected to grow to be worth US$ 2.7 Billion by 2033, with an absolute dollar growth of US$ 2.1 Billion. The market in the country has grown at a CAGR of 10.8% from 2017 to 2022 and is expected to grow at a CAGR of 16.8 % from 2023 to 2033.
According to The French National Cancer Institute, in 2018, cancer was the leading cause of death. Over 3.2 million people were diagnosed and about 1.5 million people died due to cancer. These figures are expected to propel the market in the country.
In China, the market is expected to grow to be worth US$ 2 Billion with an absolute dollar growth of US$ 1.5 Billion till 2033. The market in China has grown at a CAGR of 9.9% from 2017 to 2022 and is expected to grow at a CAGR of 15.8% from the year 2023 to 2033.
In 2020, the Chinese government, led by the National Health Commission (NHC) and the National Medical Products Administration (NMPA), confirmed approval for the chimeric antigen receptor T-cell immunotherapy (CAR-T). This therapy is used for the treatment of a specific type of blood cancer. This has helped to increase the demand for the global market.
In Japan, the market is expected to grow to be worth US$ 1.2 Billion with an absolute dollar growth of US$ 880 Million from 2023 to 2033. The market in the country has grown at a CAGR of 8.7% from 2018 to 2022 and is expected to grow at a CAGR of 15% from the year 2023 to 2033.
In 2020, the number of deaths caused by malignant neoplasms amounted to over 378 thousand and the total number of deaths in japan due to cancer reached more than 1.37 million cases. It will propel the market in the country.
The market for cell therapy is projected to witness significant growth as it has grown at a CAGR of 13.2% from 2017 to 2022 and is expected to grow at a CAGR of 17.1% from 2023 to 2033.
Cell therapy involves the transfer of whole and live cells into the body to replace damaged or diseased cells; it helps with an immune response or delivers therapies. In cell therapy, these cells are modified outside the body and then delivered to the patient. Cell therapies have made a significant impact on the treatment of blood cancers and hematologic conditions including lymphomas, leukemia, and multiple myeloma.
The Cell and Gene Therapy Manufacturing Services Market through the pharmaceuticals and biotechnology industry is projected to witness significant growth as it has grown at a CAGR of 12.8% from 2017 to 2022 and is expected to grow at a CAGR of 16.7% from 2023 to 2033.
Cell therapy involves the transfer of whole and live cells into the body to replace damaged or diseased cells and gene therapy involves the use of genetic materials for the treatment of various oncology, cardiovascular, orthopedic, ophthalmology, central nervous system, and infectious disease. This is expected to swell the demand for cell and gene therapy manufacturing services in the pharmaceutical and biotechnology industry.
Key players in the market are Lonza, Catalent, Inc., Thermo Fisher Scientific, Inc., Charles River Laboratories, and WuXi AppTec.
The companies are manufacturing cell and gene therapy manufacturing services with the use of disposable technologies; they are becoming popular in cell and gene therapy manufacturing due to their flexibility and ease of use. This may affect reducing manufacturing costs and improves product quality.
A few of the recent developments in the cell and gene therapy manufacturing services market are:
By Type:
By Indication:
By Application:
By End User:
By Region:
|
Attributes |
Details |
| Size in 2022 |
US$ 5.8 Billion |
| Forecast (Value) in 2033 |
US$ 33.9 Billion |
|
Global Market CAGR (2023 to 2033) |
17.4% |
|
U.S. Market CAGR (2023 to 2033) |
17.2% |
|
Key Companies Covered |
|
The global market is estimated to be valued at US$ 6.8 Billion in 2023.
The market was reported at US$ 5.8 Billion in 2022.
The market is expected to reach a valuation of US$ 33.9 Billion in 2033.
The market registered a CAGR of 13.9% over the last 4 years.
The market is projected to witness a CAGR of 17.4% from 2023 to 2033.
The market through cell therapy is projected to witness large demand till 2033 with an expected CAGR of 17.1% by 2033.
The Cell and Gene Therapy Manufacturing Services demand through the pharmaceutical and biotechnology industry is projected to witness significant demand between 2023 and 2033 and is expected to grow at a CAGR of 16.7%.
The market in the United States is projected to witness a market size of US$ 12 Billion and is expected to grow at a 17.2% CAGR from 2023 to 2033.
The key players in the manufacturing cell and gene therapy manufacturing services industry are Lonza, Catalent, Inc., Thermo Fisher Scientific, Inc., Charles River Laboratories, and WuXi AppTec.
1. Executive Summary
1.1. Global Market Outlook
1.2. Demand-side Trends
1.3. Supply-side Trends
1.4. Technology Roadmap Analysis
1.5. Analysis and Recommendations
2. Market Overview
2.1. Market Coverage / Taxonomy
2.2. Market Definition / Scope / Limitations
3. Market Background
3.1. Market Dynamics
3.1.1. Drivers
3.1.2. Restraints
3.1.3. Opportunity
3.1.4. Trends
3.2. Scenario Forecast
3.2.1. Demand in Optimistic Scenario
3.2.2. Demand in Likely Scenario
3.2.3. Demand in Conservative Scenario
3.3. Opportunity Map Analysis
3.4. Investment Feasibility Matrix
3.5. PESTLE and Porter’s Analysis
3.6. Regulatory Landscape
3.6.1. By Key Regions
3.6.2. By Key Countries
3.7. Regional Parent Market Outlook
4. Global Cell & Gene Therapy Manufacturing Services Market Analysis 2017-2022 and Forecast, 2023-2033
4.1. Historical Market Size Value (US$ Million) Analysis, 2017-2022
4.2. Current and Future Market Size Value (US$ Million) Projections, 2023-2033
4.2.1. Y-o-Y Growth Trend Analysis
4.2.2. Absolute $ Opportunity Analysis
5. Global Cell & Gene Therapy Manufacturing Services Market Analysis 2017-2022 and Forecast 2023-2033, By Type
5.1. Introduction / Key Findings
5.2. Historical Market Size Value (US$ Million) Analysis By Type, 2017-2022
5.3. Current and Future Market Size Value (US$ Million) Analysis and Forecast By Type, 2023-2033
5.3.1. Cell Therapy
5.3.1.1. Allogeneic
5.3.1.2. Autologous
5.3.1.3. Viral Vector
5.3.2. Gene Therapy
5.3.2.1. Viral Vector
5.3.2.2. Non-Viral Vector
5.4. Y-o-Y Growth Trend Analysis By Type, 2017-2022
5.5. Absolute $ Opportunity Analysis By Type, 2023-2033
6. Global Cell & Gene Therapy Manufacturing Services Market Analysis 2017-2022 and Forecast 2023-2033, By Indication
6.1. Introduction / Key Findings
6.2. Historical Market Size Value (US$ Million) Analysis By Indication, 2017-2022
6.3. Current and Future Market Size Value (US$ Million) Analysis and Forecast By Indication, 2023-2033
6.3.1. Oncology Diseases
6.3.2. Cardiovascular Diseases
6.3.3. Orthopedic Diseases
6.3.4. Ophthalmology Diseases
6.3.5. Central Nervous System Disorder
6.3.6. Infectious Diseases
6.3.7. Other Indications
6.4. Y-o-Y Growth Trend Analysis By Indication, 2017-2022
6.5. Absolute $ Opportunity Analysis By Indication, 2023-2033
7. Global Cell & Gene Therapy Manufacturing Services Market Analysis 2017-2022 and Forecast 2023-2033, By Applications
7.1. Introduction / Key Findings
7.2. Historical Market Size Value (US$ Million) Analysis By Applications, 2017-2022
7.3. Current and Future Market Size Value (US$ Million) Analysis and Forecast By Applications, 2023-2033
7.3.1. Clinical Manufacturing
7.3.2. Commercial Manufacturing
7.4. Y-o-Y Growth Trend Analysis By Applications, 2017-2022
7.5. Absolute $ Opportunity Analysis By Applications, 2023-2033
8. Global Cell & Gene Therapy Manufacturing Services Market Analysis 2017-2022 and Forecast 2023-2033, By End User
8.1. Introduction / Key Findings
8.2. Historical Market Size Value (US$ Million) Analysis By End User, 2017-2022
8.3. Current and Future Market Size Value (US$ Million) Analysis and Forecast By End User, 2023-2033
8.3.1. Pharmaceutical & Biotechnology Companies
8.3.2. Academic & Research Institutes
8.3.3. Others
8.4. Y-o-Y Growth Trend Analysis By End User, 2017-2022
8.5. Absolute $ Opportunity Analysis By End User, 2023-2033
9. Global Cell & Gene Therapy Manufacturing Services Market Analysis 2017-2022 and Forecast 2023-2033, By Region
9.1. Introduction
9.2. Historical Market Size Value (US$ Million) Analysis By Region, 2017-2022
9.3. Current Market Size Value (US$ Million) Analysis and Forecast By Region, 2023-2033
9.3.1. North America
9.3.2. Latin America
9.3.3. Europe
9.3.4. Asia Pacific
9.3.5. Middle East and Africa
9.4. Market Attractiveness Analysis By Region
10. North America Cell & Gene Therapy Manufacturing Services Market Analysis 2017-2022 and Forecast 2023-2033, By Country
10.1. Historical Market Size Value (US$ Million) Trend Analysis By Market Taxonomy, 2017-2022
10.2. Market Size Value (US$ Million) Forecast By Market Taxonomy, 2023-2033
10.2.1. By Country
10.2.1.1. U.S.
10.2.1.2. Canada
10.2.2. By Type
10.2.3. By Indication
10.2.4. By Applications
10.2.5. By End User
10.3. Market Attractiveness Analysis
10.3.1. By Country
10.3.2. By Type
10.3.3. By Indication
10.3.4. By Applications
10.3.5. By End User
10.4. Key Takeaways
11. Latin America Cell & Gene Therapy Manufacturing Services Market Analysis 2017-2022 and Forecast 2023-2033, By Country
11.1. Historical Market Size Value (US$ Million) Trend Analysis By Market Taxonomy, 2017-2022
11.2. Market Size Value (US$ Million) Forecast By Market Taxonomy, 2023-2033
11.2.1. By Country
11.2.1.1. Brazil
11.2.1.2. Mexico
11.2.1.3. Rest of Latin America
11.2.2. By Type
11.2.3. By Indication
11.2.4. By Applications
11.2.5. By End User
11.3. Market Attractiveness Analysis
11.3.1. By Country
11.3.2. By Type
11.3.3. By Indication
11.3.4. By Applications
11.3.5. By End User
11.4. Key Takeaways
12. Europe Cell & Gene Therapy Manufacturing Services Market Analysis 2017-2022 and Forecast 2023-2033, By Country
12.1. Historical Market Size Value (US$ Million) Trend Analysis By Market Taxonomy, 2017-2022
12.2. Market Size Value (US$ Million) Forecast By Market Taxonomy, 2023-2033
12.2.1. By Country
12.2.1.1. U.K.
12.2.1.2. Spain
12.2.1.3. Germany
12.2.1.4. Italy
12.2.1.5. France
12.2.1.6. Rest of Europe
12.2.2. By Type
12.2.3. By Indication
12.2.4. By Applications
12.2.5. By End User
12.3. Market Attractiveness Analysis
12.3.1. By Country
12.3.2. By Type
12.3.3. By Indication
12.3.4. By Applications
12.3.5. By End User
12.4. Key Takeaways
13. Asia Pacific Cell & Gene Therapy Manufacturing Services Market Analysis 2017-2022 and Forecast 2023-2033, By Country
13.1. Historical Market Size Value (US$ Million) Trend Analysis By Market Taxonomy, 2017-2022
13.2. Market Size Value (US$ Million) Forecast By Market Taxonomy, 2023-2033
13.2.1. By Country
13.2.1.1. India
13.2.1.2. China
13.2.1.3. Japan
13.2.1.4. Rest of Asia Pacific
13.2.2. By Type
13.2.3. By Indication
13.2.4. By Applications
13.2.5. By End User
13.3. Market Attractiveness Analysis
13.3.1. By Country
13.3.2. By Type
13.3.3. By Indication
13.3.4. By Applications
13.3.5. By End User
13.4. Key Takeaways
14. Middle East and Africa Cell & Gene Therapy Manufacturing Services Market Analysis 2017-2022 and Forecast 2023-2033, By Country
14.1. Historical Market Size Value (US$ Million) Trend Analysis By Market Taxonomy, 2017-2022
14.2. Market Size Value (US$ Million) Forecast By Market Taxonomy, 2023-2033
14.2.1. By Country
14.2.1.1. South Africa
14.2.1.2. GCC Countries
14.2.1.3. Rest of Middle East and Africa
14.2.2. By Type
14.2.3. By Indication
14.2.4. By Applications
14.2.5. By End User
14.3. Market Attractiveness Analysis
14.3.1. By Country
14.3.2. By Type
14.3.3. By Indication
14.3.4. By Applications
14.3.5. By End User
14.4. Key Takeaways
15. Key Countries Cell & Gene Therapy Manufacturing Services Market Analysis
15.1. U.S.
15.1.1. Pricing Analysis
15.1.2. Market Share Analysis, 2022
15.1.2.1. By Type
15.1.2.2. By Indication
15.1.2.3. By Applications
15.1.2.4. By End User
15.2. Canada
15.2.1. Pricing Analysis
15.2.2. Market Share Analysis, 2022
15.2.2.1. By Type
15.2.2.2. By Indication
15.2.2.3. By Applications
15.2.2.4. By End User
15.3. Brazil
15.3.1. Pricing Analysis
15.3.2. Market Share Analysis, 2022
15.3.2.1. By Type
15.3.2.2. By Indication
15.3.2.3. By Applications
15.3.2.4. By End User
15.4. Mexico
15.4.1. Pricing Analysis
15.4.2. Market Share Analysis, 2022
15.4.2.1. By Type
15.4.2.2. By Indication
15.4.2.3. By Applications
15.4.2.4. By End User
15.5. U.K.
15.5.1. Pricing Analysis
15.5.2. Market Share Analysis, 2022
15.5.2.1. By Type
15.5.2.2. By Indication
15.5.2.3. By Applications
15.5.2.4. By End User
15.6. Spain
15.6.1. Pricing Analysis
15.6.2. Market Share Analysis, 2022
15.6.2.1. By Type
15.6.2.2. By Indication
15.6.2.3. By Applications
15.6.2.4. By End User
15.7. Germany
15.7.1. Pricing Analysis
15.7.2. Market Share Analysis, 2022
15.7.2.1. By Type
15.7.2.2. By Indication
15.7.2.3. By Applications
15.7.2.4. By End User
15.8. Italy
15.8.1. Pricing Analysis
15.8.2. Market Share Analysis, 2022
15.8.2.1. By Type
15.8.2.2. By Indication
15.8.2.3. By Applications
15.8.2.4. By End User
15.9. France
15.9.1. Pricing Analysis
15.9.2. Market Share Analysis, 2022
15.9.2.1. By Type
15.9.2.2. By Indication
15.9.2.3. By Applications
15.9.2.4. By End User
15.10. India
15.10.1. Pricing Analysis
15.10.2. Market Share Analysis, 2022
15.10.2.1. By Type
15.10.2.2. By Indication
15.10.2.3. By Applications
15.10.2.4. By End User
15.11. China
15.11.1. Pricing Analysis
15.11.2. Market Share Analysis, 2022
15.11.2.1. By Type
15.11.2.2. By Indication
15.11.2.3. By Applications
15.11.2.4. By End User
15.12. Japan
15.12.1. Pricing Analysis
15.12.2. Market Share Analysis, 2022
15.12.2.1. By Type
15.12.2.2. By Indication
15.12.2.3. By Applications
15.12.2.4. By End User
15.13. Australia & New Zealand
15.13.1. Pricing Analysis
15.13.2. Market Share Analysis, 2022
15.13.2.1. By Type
15.13.2.2. By Indication
15.13.2.3. By Applications
15.13.2.4. By End User
15.14. South Africa
15.14.1. Pricing Analysis
15.14.2. Market Share Analysis, 2022
15.14.2.1. By Type
15.14.2.2. By Indication
15.14.2.3. By Applications
15.14.2.4. By End User
15.15. GCC Countries
15.15.1. Pricing Analysis
15.15.2. Market Share Analysis, 2022
15.15.2.1. By Type
15.15.2.2. By Indication
15.15.2.3. By Applications
15.15.2.4. By End User
16. Market Structure Analysis
16.1. Competition Dashboard
16.2. Competition Benchmarking
16.3. Market Share Analysis of Top Players
16.3.1. By Regional
16.3.2. By Type
16.3.3. By Indication
16.3.4. By Applications
16.3.5. By End User
17. Competition Analysis
17.1. Competition Deep Dive
17.1.1. Lonza
17.1.1.1. Overview
17.1.1.2. Product Portfolio
17.1.1.3. Profitability by Market Segments
17.1.1.4. Sales Footprint
17.1.1.5. Strategy Overview
17.1.1.5.1. Marketing Strategy
17.1.2. Catalent, Inc.
17.1.2.1. Overview
17.1.2.2. Product Portfolio
17.1.2.3. Profitability by Market Segments
17.1.2.4. Sales Footprint
17.1.2.5. Strategy Overview
17.1.2.5.1. Marketing Strategy
17.1.3. Thermo Fisher Scientific, Inc.
17.1.3.1. Overview
17.1.3.2. Product Portfolio
17.1.3.3. Profitability by Market Segments
17.1.3.4. Sales Footprint
17.1.3.5. Strategy Overview
17.1.3.5.1. Marketing Strategy
17.1.4. Charles River Laboratories
17.1.4.1. Overview
17.1.4.2. Product Portfolio
17.1.4.3. Profitability by Market Segments
17.1.4.4. Sales Footprint
17.1.4.5. Strategy Overview
17.1.4.5.1. Marketing Strategy
17.1.5. WuXi AppTec
17.1.5.1. Overview
17.1.5.2. Product Portfolio
17.1.5.3. Profitability by Market Segments
17.1.5.4. Sales Footprint
17.1.5.5. Strategy Overview
17.1.5.5.1. Marketing Strategy
17.1.6. Merch KGaA
17.1.6.1. Overview
17.1.6.2. Product Portfolio
17.1.6.3. Profitability by Market Segments
17.1.6.4. Sales Footprint
17.1.6.5. Strategy Overview
17.1.6.5.1. Marketing Strategy
17.1.7. Takara Bio Inc.
17.1.7.1. Overview
17.1.7.2. Product Portfolio
17.1.7.3. Profitability by Market Segments
17.1.7.4. Sales Footprint
17.1.7.5. Strategy Overview
17.1.7.5.1. Marketing Strategy
17.1.8. Oxford Biomedica
17.1.8.1. Overview
17.1.8.2. Product Portfolio
17.1.8.3. Profitability by Market Segments
17.1.8.4. Sales Footprint
17.1.8.5. Strategy Overview
17.1.8.5.1. Marketing Strategy
17.1.9. Novartis
17.1.9.1. Overview
17.1.9.2. Product Portfolio
17.1.9.3. Profitability by Market Segments
17.1.9.4. Sales Footprint
17.1.9.5. Strategy Overview
17.1.9.5.1. Marketing Strategy
17.1.10. Genezen
17.1.10.1. Overview
17.1.10.2. Product Portfolio
17.1.10.3. Profitability by Market Segments
17.1.10.4. Sales Footprint
17.1.10.5. Strategy Overview
17.1.10.5.1. Marketing Strategy
17.1.11. Discovery Life Sciences
17.1.11.1. Overview
17.1.11.2. Product Portfolio
17.1.11.3. Profitability by Market Segments
17.1.11.4. Sales Footprint
17.1.11.5. Strategy Overview
17.1.11.5.1. Marketing Strategy
18. Assumptions & Acronyms Used
19. Research Methodology
List of Tables
Table 1: Global Cell & Gene Therapy Manufacturing Services Market Value (US$ Million) Forecast by Region, 2017-2033
Table 2: Global Cell & Gene Therapy Manufacturing Services Market Value (US$ Million) Forecast by Type, 2017-2033
Table 3: Global Cell & Gene Therapy Manufacturing Services Market Value (US$ Million) Forecast by Indication, 2017-2033
Table 4: Global Cell & Gene Therapy Manufacturing Services Market Value (US$ Million) Forecast by Applications , 2017-2033
Table 5: Global Cell & Gene Therapy Manufacturing Services Market Value (US$ Million) Forecast by End User, 2017-2033
Table 6: North America Cell & Gene Therapy Manufacturing Services Market Value (US$ Million) Forecast by Country, 2017-2033
Table 7: North America Cell & Gene Therapy Manufacturing Services Market Value (US$ Million) Forecast by Type, 2017-2033
Table 8: North America Cell & Gene Therapy Manufacturing Services Market Value (US$ Million) Forecast by Indication, 2017-2033
Table 9: North America Cell & Gene Therapy Manufacturing Services Market Value (US$ Million) Forecast by Applications , 2017-2033
Table 10: North America Cell & Gene Therapy Manufacturing Services Market Value (US$ Million) Forecast by End User, 2017-2033
Table 11: Latin America Cell & Gene Therapy Manufacturing Services Market Value (US$ Million) Forecast by Country, 2017-2033
Table 12: Latin America Cell & Gene Therapy Manufacturing Services Market Value (US$ Million) Forecast by Type, 2017-2033
Table 13: Latin America Cell & Gene Therapy Manufacturing Services Market Value (US$ Million) Forecast by Indication, 2017-2033
Table 14: Latin America Cell & Gene Therapy Manufacturing Services Market Value (US$ Million) Forecast by Applications , 2017-2033
Table 15: Latin America Cell & Gene Therapy Manufacturing Services Market Value (US$ Million) Forecast by End User, 2017-2033
Table 16: Europe Cell & Gene Therapy Manufacturing Services Market Value (US$ Million) Forecast by Country, 2017-2033
Table 17: Europe Cell & Gene Therapy Manufacturing Services Market Value (US$ Million) Forecast by Type, 2017-2033
Table 18: Europe Cell & Gene Therapy Manufacturing Services Market Value (US$ Million) Forecast by Indication, 2017-2033
Table 19: Europe Cell & Gene Therapy Manufacturing Services Market Value (US$ Million) Forecast by Applications , 2017-2033
Table 20: Europe Cell & Gene Therapy Manufacturing Services Market Value (US$ Million) Forecast by End User, 2017-2033
Table 21: Asia Pacific Cell & Gene Therapy Manufacturing Services Market Value (US$ Million) Forecast by Country, 2017-2033
Table 22: Asia Pacific Cell & Gene Therapy Manufacturing Services Market Value (US$ Million) Forecast by Type, 2017-2033
Table 23: Asia Pacific Cell & Gene Therapy Manufacturing Services Market Value (US$ Million) Forecast by Indication, 2017-2033
Table 24: Asia Pacific Cell & Gene Therapy Manufacturing Services Market Value (US$ Million) Forecast by Applications , 2017-2033
Table 25: Asia Pacific Cell & Gene Therapy Manufacturing Services Market Value (US$ Million) Forecast by End User, 2017-2033
Table 26: Middle East and Africa Cell & Gene Therapy Manufacturing Services Market Value (US$ Million) Forecast by Country, 2017-2033
Table 27: Middle East and Africa Cell & Gene Therapy Manufacturing Services Market Value (US$ Million) Forecast by Type, 2017-2033
Table 28: Middle East and Africa Cell & Gene Therapy Manufacturing Services Market Value (US$ Million) Forecast by Indication, 2017-2033
Table 29: Middle East and Africa Cell & Gene Therapy Manufacturing Services Market Value (US$ Million) Forecast by Applications , 2017-2033
Table 30: Middle East and Africa Cell & Gene Therapy Manufacturing Services Market Value (US$ Million) Forecast by End User, 2017-2033
List of Figures
Figure 1: Global Cell & Gene Therapy Manufacturing Services Market Value (US$ Million) by Type, 2023-2033
Figure 2: Global Cell & Gene Therapy Manufacturing Services Market Value (US$ Million) by Indication, 2023-2033
Figure 3: Global Cell & Gene Therapy Manufacturing Services Market Value (US$ Million) by Applications , 2023-2033
Figure 4: Global Cell & Gene Therapy Manufacturing Services Market Value (US$ Million) by End User, 2023-2033
Figure 5: Global Cell & Gene Therapy Manufacturing Services Market Value (US$ Million) by Region, 2023-2033
Figure 6: Global Cell & Gene Therapy Manufacturing Services Market Value (US$ Million) Analysis by Region, 2017-2033
Figure 7: Global Cell & Gene Therapy Manufacturing Services Market Value Share (%) and BPS Analysis by Region, 2023-2033
Figure 8: Global Cell & Gene Therapy Manufacturing Services Market Y-o-Y Growth (%) Projections by Region, 2023-2033
Figure 9: Global Cell & Gene Therapy Manufacturing Services Market Value (US$ Million) Analysis by Type, 2017-2033
Figure 10: Global Cell & Gene Therapy Manufacturing Services Market Value Share (%) and BPS Analysis by Type, 2023-2033
Figure 11: Global Cell & Gene Therapy Manufacturing Services Market Y-o-Y Growth (%) Projections by Type, 2023-2033
Figure 12: Global Cell & Gene Therapy Manufacturing Services Market Value (US$ Million) Analysis by Indication, 2017-2033
Figure 13: Global Cell & Gene Therapy Manufacturing Services Market Value Share (%) and BPS Analysis by Indication, 2023-2033
Figure 14: Global Cell & Gene Therapy Manufacturing Services Market Y-o-Y Growth (%) Projections by Indication, 2023-2033
Figure 15: Global Cell & Gene Therapy Manufacturing Services Market Value (US$ Million) Analysis by Applications , 2017-2033
Figure 16: Global Cell & Gene Therapy Manufacturing Services Market Value Share (%) and BPS Analysis by Applications , 2023-2033
Figure 17: Global Cell & Gene Therapy Manufacturing Services Market Y-o-Y Growth (%) Projections by Applications , 2023-2033
Figure 18: Global Cell & Gene Therapy Manufacturing Services Market Value (US$ Million) Analysis by End User, 2017-2033
Figure 19: Global Cell & Gene Therapy Manufacturing Services Market Value Share (%) and BPS Analysis by End User, 2023-2033
Figure 20: Global Cell & Gene Therapy Manufacturing Services Market Y-o-Y Growth (%) Projections by End User, 2023-2033
Figure 21: Global Cell & Gene Therapy Manufacturing Services Market Attractiveness by Type, 2023-2033
Figure 22: Global Cell & Gene Therapy Manufacturing Services Market Attractiveness by Indication, 2023-2033
Figure 23: Global Cell & Gene Therapy Manufacturing Services Market Attractiveness by Applications , 2023-2033
Figure 24: Global Cell & Gene Therapy Manufacturing Services Market Attractiveness by End User, 2023-2033
Figure 25: Global Cell & Gene Therapy Manufacturing Services Market Attractiveness by Region, 2023-2033
Figure 26: North America Cell & Gene Therapy Manufacturing Services Market Value (US$ Million) by Type, 2023-2033
Figure 27: North America Cell & Gene Therapy Manufacturing Services Market Value (US$ Million) by Indication, 2023-2033
Figure 28: North America Cell & Gene Therapy Manufacturing Services Market Value (US$ Million) by Applications , 2023-2033
Figure 29: North America Cell & Gene Therapy Manufacturing Services Market Value (US$ Million) by End User, 2023-2033
Figure 30: North America Cell & Gene Therapy Manufacturing Services Market Value (US$ Million) by Country, 2023-2033
Figure 31: North America Cell & Gene Therapy Manufacturing Services Market Value (US$ Million) Analysis by Country, 2017-2033
Figure 32: North America Cell & Gene Therapy Manufacturing Services Market Value Share (%) and BPS Analysis by Country, 2023-2033
Figure 33: North America Cell & Gene Therapy Manufacturing Services Market Y-o-Y Growth (%) Projections by Country, 2023-2033
Figure 34: North America Cell & Gene Therapy Manufacturing Services Market Value (US$ Million) Analysis by Type, 2017-2033
Figure 35: North America Cell & Gene Therapy Manufacturing Services Market Value Share (%) and BPS Analysis by Type, 2023-2033
Figure 36: North America Cell & Gene Therapy Manufacturing Services Market Y-o-Y Growth (%) Projections by Type, 2023-2033
Figure 37: North America Cell & Gene Therapy Manufacturing Services Market Value (US$ Million) Analysis by Indication, 2017-2033
Figure 38: North America Cell & Gene Therapy Manufacturing Services Market Value Share (%) and BPS Analysis by Indication, 2023-2033
Figure 39: North America Cell & Gene Therapy Manufacturing Services Market Y-o-Y Growth (%) Projections by Indication, 2023-2033
Figure 40: North America Cell & Gene Therapy Manufacturing Services Market Value (US$ Million) Analysis by Applications , 2017-2033
Figure 41: North America Cell & Gene Therapy Manufacturing Services Market Value Share (%) and BPS Analysis by Applications , 2023-2033
Figure 42: North America Cell & Gene Therapy Manufacturing Services Market Y-o-Y Growth (%) Projections by Applications , 2023-2033
Figure 43: North America Cell & Gene Therapy Manufacturing Services Market Value (US$ Million) Analysis by End User, 2017-2033
Figure 44: North America Cell & Gene Therapy Manufacturing Services Market Value Share (%) and BPS Analysis by End User, 2023-2033
Figure 45: North America Cell & Gene Therapy Manufacturing Services Market Y-o-Y Growth (%) Projections by End User, 2023-2033
Figure 46: North America Cell & Gene Therapy Manufacturing Services Market Attractiveness by Type, 2023-2033
Figure 47: North America Cell & Gene Therapy Manufacturing Services Market Attractiveness by Indication, 2023-2033
Figure 48: North America Cell & Gene Therapy Manufacturing Services Market Attractiveness by Applications , 2023-2033
Figure 49: North America Cell & Gene Therapy Manufacturing Services Market Attractiveness by End User, 2023-2033
Figure 50: North America Cell & Gene Therapy Manufacturing Services Market Attractiveness by Country, 2023-2033
Figure 51: Latin America Cell & Gene Therapy Manufacturing Services Market Value (US$ Million) by Type, 2023-2033
Figure 52: Latin America Cell & Gene Therapy Manufacturing Services Market Value (US$ Million) by Indication, 2023-2033
Figure 53: Latin America Cell & Gene Therapy Manufacturing Services Market Value (US$ Million) by Applications , 2023-2033
Figure 54: Latin America Cell & Gene Therapy Manufacturing Services Market Value (US$ Million) by End User, 2023-2033
Figure 55: Latin America Cell & Gene Therapy Manufacturing Services Market Value (US$ Million) by Country, 2023-2033
Figure 56: Latin America Cell & Gene Therapy Manufacturing Services Market Value (US$ Million) Analysis by Country, 2017-2033
Figure 57: Latin America Cell & Gene Therapy Manufacturing Services Market Value Share (%) and BPS Analysis by Country, 2023-2033
Figure 58: Latin America Cell & Gene Therapy Manufacturing Services Market Y-o-Y Growth (%) Projections by Country, 2023-2033
Figure 59: Latin America Cell & Gene Therapy Manufacturing Services Market Value (US$ Million) Analysis by Type, 2017-2033
Figure 60: Latin America Cell & Gene Therapy Manufacturing Services Market Value Share (%) and BPS Analysis by Type, 2023-2033
Figure 61: Latin America Cell & Gene Therapy Manufacturing Services Market Y-o-Y Growth (%) Projections by Type, 2023-2033
Figure 62: Latin America Cell & Gene Therapy Manufacturing Services Market Value (US$ Million) Analysis by Indication, 2017-2033
Figure 63: Latin America Cell & Gene Therapy Manufacturing Services Market Value Share (%) and BPS Analysis by Indication, 2023-2033
Figure 64: Latin America Cell & Gene Therapy Manufacturing Services Market Y-o-Y Growth (%) Projections by Indication, 2023-2033
Figure 65: Latin America Cell & Gene Therapy Manufacturing Services Market Value (US$ Million) Analysis by Applications , 2017-2033
Figure 66: Latin America Cell & Gene Therapy Manufacturing Services Market Value Share (%) and BPS Analysis by Applications , 2023-2033
Figure 67: Latin America Cell & Gene Therapy Manufacturing Services Market Y-o-Y Growth (%) Projections by Applications , 2023-2033
Figure 68: Latin America Cell & Gene Therapy Manufacturing Services Market Value (US$ Million) Analysis by End User, 2017-2033
Figure 69: Latin America Cell & Gene Therapy Manufacturing Services Market Value Share (%) and BPS Analysis by End User, 2023-2033
Figure 70: Latin America Cell & Gene Therapy Manufacturing Services Market Y-o-Y Growth (%) Projections by End User, 2023-2033
Figure 71: Latin America Cell & Gene Therapy Manufacturing Services Market Attractiveness by Type, 2023-2033
Figure 72: Latin America Cell & Gene Therapy Manufacturing Services Market Attractiveness by Indication, 2023-2033
Figure 73: Latin America Cell & Gene Therapy Manufacturing Services Market Attractiveness by Applications , 2023-2033
Figure 74: Latin America Cell & Gene Therapy Manufacturing Services Market Attractiveness by End User, 2023-2033
Figure 75: Latin America Cell & Gene Therapy Manufacturing Services Market Attractiveness by Country, 2023-2033
Figure 76: Europe Cell & Gene Therapy Manufacturing Services Market Value (US$ Million) by Type, 2023-2033
Figure 77: Europe Cell & Gene Therapy Manufacturing Services Market Value (US$ Million) by Indication, 2023-2033
Figure 78: Europe Cell & Gene Therapy Manufacturing Services Market Value (US$ Million) by Applications , 2023-2033
Figure 79: Europe Cell & Gene Therapy Manufacturing Services Market Value (US$ Million) by End User, 2023-2033
Figure 80: Europe Cell & Gene Therapy Manufacturing Services Market Value (US$ Million) by Country, 2023-2033
Figure 81: Europe Cell & Gene Therapy Manufacturing Services Market Value (US$ Million) Analysis by Country, 2017-2033
Figure 82: Europe Cell & Gene Therapy Manufacturing Services Market Value Share (%) and BPS Analysis by Country, 2023-2033
Figure 83: Europe Cell & Gene Therapy Manufacturing Services Market Y-o-Y Growth (%) Projections by Country, 2023-2033
Figure 84: Europe Cell & Gene Therapy Manufacturing Services Market Value (US$ Million) Analysis by Type, 2017-2033
Figure 85: Europe Cell & Gene Therapy Manufacturing Services Market Value Share (%) and BPS Analysis by Type, 2023-2033
Figure 86: Europe Cell & Gene Therapy Manufacturing Services Market Y-o-Y Growth (%) Projections by Type, 2023-2033
Figure 87: Europe Cell & Gene Therapy Manufacturing Services Market Value (US$ Million) Analysis by Indication, 2017-2033
Figure 88: Europe Cell & Gene Therapy Manufacturing Services Market Value Share (%) and BPS Analysis by Indication, 2023-2033
Figure 89: Europe Cell & Gene Therapy Manufacturing Services Market Y-o-Y Growth (%) Projections by Indication, 2023-2033
Figure 90: Europe Cell & Gene Therapy Manufacturing Services Market Value (US$ Million) Analysis by Applications , 2017-2033
Figure 91: Europe Cell & Gene Therapy Manufacturing Services Market Value Share (%) and BPS Analysis by Applications , 2023-2033
Figure 92: Europe Cell & Gene Therapy Manufacturing Services Market Y-o-Y Growth (%) Projections by Applications , 2023-2033
Figure 93: Europe Cell & Gene Therapy Manufacturing Services Market Value (US$ Million) Analysis by End User, 2017-2033
Figure 94: Europe Cell & Gene Therapy Manufacturing Services Market Value Share (%) and BPS Analysis by End User, 2023-2033
Figure 95: Europe Cell & Gene Therapy Manufacturing Services Market Y-o-Y Growth (%) Projections by End User, 2023-2033
Figure 96: Europe Cell & Gene Therapy Manufacturing Services Market Attractiveness by Type, 2023-2033
Figure 97: Europe Cell & Gene Therapy Manufacturing Services Market Attractiveness by Indication, 2023-2033
Figure 98: Europe Cell & Gene Therapy Manufacturing Services Market Attractiveness by Applications , 2023-2033
Figure 99: Europe Cell & Gene Therapy Manufacturing Services Market Attractiveness by End User, 2023-2033
Figure 100: Europe Cell & Gene Therapy Manufacturing Services Market Attractiveness by Country, 2023-2033
Figure 101: Asia Pacific Cell & Gene Therapy Manufacturing Services Market Value (US$ Million) by Type, 2023-2033
Figure 102: Asia Pacific Cell & Gene Therapy Manufacturing Services Market Value (US$ Million) by Indication, 2023-2033
Figure 103: Asia Pacific Cell & Gene Therapy Manufacturing Services Market Value (US$ Million) by Applications , 2023-2033
Figure 104: Asia Pacific Cell & Gene Therapy Manufacturing Services Market Value (US$ Million) by End User, 2023-2033
Figure 105: Asia Pacific Cell & Gene Therapy Manufacturing Services Market Value (US$ Million) by Country, 2023-2033
Figure 106: Asia Pacific Cell & Gene Therapy Manufacturing Services Market Value (US$ Million) Analysis by Country, 2017-2033
Figure 107: Asia Pacific Cell & Gene Therapy Manufacturing Services Market Value Share (%) and BPS Analysis by Country, 2023-2033
Figure 108: Asia Pacific Cell & Gene Therapy Manufacturing Services Market Y-o-Y Growth (%) Projections by Country, 2023-2033
Figure 109: Asia Pacific Cell & Gene Therapy Manufacturing Services Market Value (US$ Million) Analysis by Type, 2017-2033
Figure 110: Asia Pacific Cell & Gene Therapy Manufacturing Services Market Value Share (%) and BPS Analysis by Type, 2023-2033
Figure 111: Asia Pacific Cell & Gene Therapy Manufacturing Services Market Y-o-Y Growth (%) Projections by Type, 2023-2033
Figure 112: Asia Pacific Cell & Gene Therapy Manufacturing Services Market Value (US$ Million) Analysis by Indication, 2017-2033
Figure 113: Asia Pacific Cell & Gene Therapy Manufacturing Services Market Value Share (%) and BPS Analysis by Indication, 2023-2033
Figure 114: Asia Pacific Cell & Gene Therapy Manufacturing Services Market Y-o-Y Growth (%) Projections by Indication, 2023-2033
Figure 115: Asia Pacific Cell & Gene Therapy Manufacturing Services Market Value (US$ Million) Analysis by Applications , 2017-2033
Figure 116: Asia Pacific Cell & Gene Therapy Manufacturing Services Market Value Share (%) and BPS Analysis by Applications , 2023-2033
Figure 117: Asia Pacific Cell & Gene Therapy Manufacturing Services Market Y-o-Y Growth (%) Projections by Applications , 2023-2033
Figure 118: Asia Pacific Cell & Gene Therapy Manufacturing Services Market Value (US$ Million) Analysis by End User, 2017-2033
Figure 119: Asia Pacific Cell & Gene Therapy Manufacturing Services Market Value Share (%) and BPS Analysis by End User, 2023-2033
Figure 120: Asia Pacific Cell & Gene Therapy Manufacturing Services Market Y-o-Y Growth (%) Projections by End User, 2023-2033
Figure 121: Asia Pacific Cell & Gene Therapy Manufacturing Services Market Attractiveness by Type, 2023-2033
Figure 122: Asia Pacific Cell & Gene Therapy Manufacturing Services Market Attractiveness by Indication, 2023-2033
Figure 123: Asia Pacific Cell & Gene Therapy Manufacturing Services Market Attractiveness by Applications , 2023-2033
Figure 124: Asia Pacific Cell & Gene Therapy Manufacturing Services Market Attractiveness by End User, 2023-2033
Figure 125: Asia Pacific Cell & Gene Therapy Manufacturing Services Market Attractiveness by Country, 2023-2033
Figure 126: Middle East and Africa Cell & Gene Therapy Manufacturing Services Market Value (US$ Million) by Type, 2023-2033
Figure 127: Middle East and Africa Cell & Gene Therapy Manufacturing Services Market Value (US$ Million) by Indication, 2023-2033
Figure 128: Middle East and Africa Cell & Gene Therapy Manufacturing Services Market Value (US$ Million) by Applications , 2023-2033
Figure 129: Middle East and Africa Cell & Gene Therapy Manufacturing Services Market Value (US$ Million) by End User, 2023-2033
Figure 130: Middle East and Africa Cell & Gene Therapy Manufacturing Services Market Value (US$ Million) by Country, 2023-2033
Figure 131: Middle East and Africa Cell & Gene Therapy Manufacturing Services Market Value (US$ Million) Analysis by Country, 2017-2033
Figure 132: Middle East and Africa Cell & Gene Therapy Manufacturing Services Market Value Share (%) and BPS Analysis by Country, 2023-2033
Figure 133: Middle East and Africa Cell & Gene Therapy Manufacturing Services Market Y-o-Y Growth (%) Projections by Country, 2023-2033
Figure 134: Middle East and Africa Cell & Gene Therapy Manufacturing Services Market Value (US$ Million) Analysis by Type, 2017-2033
Figure 135: Middle East and Africa Cell & Gene Therapy Manufacturing Services Market Value Share (%) and BPS Analysis by Type, 2023-2033
Figure 136: Middle East and Africa Cell & Gene Therapy Manufacturing Services Market Y-o-Y Growth (%) Projections by Type, 2023-2033
Figure 137: Middle East and Africa Cell & Gene Therapy Manufacturing Services Market Value (US$ Million) Analysis by Indication, 2017-2033
Figure 138: Middle East and Africa Cell & Gene Therapy Manufacturing Services Market Value Share (%) and BPS Analysis by Indication, 2023-2033
Figure 139: Middle East and Africa Cell & Gene Therapy Manufacturing Services Market Y-o-Y Growth (%) Projections by Indication, 2023-2033
Figure 140: Middle East and Africa Cell & Gene Therapy Manufacturing Services Market Value (US$ Million) Analysis by Applications , 2017-2033
Figure 141: Middle East and Africa Cell & Gene Therapy Manufacturing Services Market Value Share (%) and BPS Analysis by Applications , 2023-2033
Figure 142: Middle East and Africa Cell & Gene Therapy Manufacturing Services Market Y-o-Y Growth (%) Projections by Applications , 2023-2033
Figure 143: Middle East and Africa Cell & Gene Therapy Manufacturing Services Market Value (US$ Million) Analysis by End User, 2017-2033
Figure 144: Middle East and Africa Cell & Gene Therapy Manufacturing Services Market Value Share (%) and BPS Analysis by End User, 2023-2033
Figure 145: Middle East and Africa Cell & Gene Therapy Manufacturing Services Market Y-o-Y Growth (%) Projections by End User, 2023-2033
Figure 146: Middle East and Africa Cell & Gene Therapy Manufacturing Services Market Attractiveness by Type, 2023-2033
Figure 147: Middle East and Africa Cell & Gene Therapy Manufacturing Services Market Attractiveness by Indication, 2023-2033
Figure 148: Middle East and Africa Cell & Gene Therapy Manufacturing Services Market Attractiveness by Applications , 2023-2033
Figure 149: Middle East and Africa Cell & Gene Therapy Manufacturing Services Market Attractiveness by End User, 2023-2033
Figure 150: Middle East and Africa Cell & Gene Therapy Manufacturing Services Market Attractiveness by Country, 2023-2033
Copyright © Transparency Market Research, Inc. All Rights reserved
Trust Online
Global Cell and Gene Therapy Manufacturing Services Market
*86 figures and 60 tables includes